Adding a P2Y12 inhibitor does not improve outcomes in COVID-19
(HealthDay)—The addition of a P2Y12 inhibitor to anticoagulant therapy does not improve organ support-free days among non-critically ill patients hospitalized for COVID-19, according to a study published in the Jan. 18 ...
Jan 19, 2022
0
2